We serve Chemical Name:(4-methoxy-3-methylphenyl)methanamine CAS:108125-07-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(4-methoxy-3-methylphenyl)methanamine
CAS.NO:108125-07-1
Synonyms:{[3-methyl-4-(methyloxy)phenyl]methyl}amine;(4-methoxy-3-methylphenyl)-methanamine;4-methoxy-3-methyl-benzylamine;Benzenemethanamine,4-methoxy-3-methyl;3-METHYL-4-METHOXYBENZYLAMINE
Molecular Formula:C9H13NO
Molecular Weight:151.20600
HS Code:2922199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:35.25000
Exact Mass:151.10000
LogP:2.16260
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like {[3-methyl-4-(methyloxy)phenyl]methyl}amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-METHYL-4-METHOXYBENZYLAMINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4-methoxy-3-methylphenyl)-methanamine Use and application,4-methoxy-3-methyl-benzylamine technical grade,usp/ep/jp grade.
Related News: The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. (4-methoxy-3-methylphenyl)methanamine manufacturer With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce. (4-methoxy-3-methylphenyl)methanamine supplier The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. (4-methoxy-3-methylphenyl)methanamine vendor With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce. (4-methoxy-3-methylphenyl)methanamine factory China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.
